Keir S - Search Results

1

Activity of 9-dimethylaminomethyl-10-hydroxycamptothecin against pediatric and adult central nervous system tumor xenografts.

Friedman HS, Houghton PJ, Schold SC, Keir S, Bigner DD. Friedman HS, et al. Among authors: keir s. Cancer Chemother Pharmacol. 1994;34(2):171-4. doi: 10.1007/BF00685936. Cancer Chemother Pharmacol. 1994. PMID: 8194169

2

Activity of temozolomide in the treatment of central nervous system tumor xenografts.

Friedman HS, Dolan ME, Pegg AE, Marcelli S, Keir S, Catino JJ, Bigner DD, Schold SC Jr. Friedman HS, et al. Among authors: keir s. Cancer Res. 1995 Jul 1;55(13):2853-7. Cancer Res. 1995. PMID: 7796412

3

Busulfan therapy of central nervous system xenografts in athymic mice.

Aaron RH, Elion GB, Colvin OM, Graham M, Keir S, Bigner DD, Friedman HS. Aaron RH, et al. Among authors: keir s. Cancer Chemother Pharmacol. 1994;35(2):127-31. doi: 10.1007/BF00686634. Cancer Chemother Pharmacol. 1994. PMID: 7987988

4

Localisation of [131I]MIBG in nude mice bearing SK-N-SH human neuroblastoma xenografts: effect of specific activity.

Vaidyanathan G, Friedman HS, Keir ST, Zalutsky MR. Vaidyanathan G, et al. Among authors: keir st. Br J Cancer. 1996 May;73(10):1171-7. doi: 10.1038/bjc.1996.226. Br J Cancer. 1996. PMID: 8630274 Free PMC article.

5

Enhancement of melphalan activity by inhibition of DNA polymerase-alpha and DNA polymerase-beta.

Moynihan K, Elion GB, Ali-Osman F, Marcelli S, Keir S, Bigner DD, Friedman HS. Moynihan K, et al. Among authors: keir s. Cancer Chemother Pharmacol. 1996;38(4):349-54. doi: 10.1007/s002800050494. Cancer Chemother Pharmacol. 1996. PMID: 8674158

6

Evaluation of meta-[211At]astatobenzylguanidine in an athymic mouse human neuroblastoma xenograft model.

Vaidyanathan G, Friedman HS, Keir ST, Zalutsky MR. Vaidyanathan G, et al. Among authors: keir st. Nucl Med Biol. 1996 Aug;23(6):851-6. doi: 10.1016/0969-8051(96)00115-1. Nucl Med Biol. 1996. PMID: 8940730

7

Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against pediatric and adult central nervous system tumor xenografts.

Hare CB, Elion GB, Houghton PJ, Houghton JA, Keir S, Marcelli SL, Bigner DD, Friedman HS. Hare CB, et al. Among authors: keir s. Cancer Chemother Pharmacol. 1997;39(3):187-91. doi: 10.1007/s002800050558. Cancer Chemother Pharmacol. 1997. PMID: 8996518

8

Methylator resistance mediated by mismatch repair deficiency in a glioblastoma multiforme xenograft.

Friedman HS, Johnson SP, Dong Q, Schold SC, Rasheed BK, Bigner SH, Ali-Osman F, Dolan E, Colvin OM, Houghton P, Germain G, Drummond JT, Keir S, Marcelli S, Bigner DD, Modrich P. Friedman HS, et al. Among authors: keir s. Cancer Res. 1997 Jul 15;57(14):2933-6. Cancer Res. 1997. PMID: 9230204

9

Characterization of the mechanisms of busulfan resistance in a human glioblastoma multiforme xenograft.

Hare CB, Elion GB, Colvin OM, Ali-Osman F, Griffith OW, Petros WP, Keir S, Marcelli SL, Bigner DD, Friedman HS. Hare CB, et al. Among authors: keir s. Cancer Chemother Pharmacol. 1997;40(5):409-14. doi: 10.1007/s002800050678. Cancer Chemother Pharmacol. 1997. PMID: 9272117

10

Enhancement of irinotecan (CPT-11) activity against central nervous system tumor xenografts by alkylating agents.

Coggins CA, Elion GB, Houghton PJ, Hare CB, Keir S, Colvin OM, Bigner DD, Friedman HS. Coggins CA, et al. Among authors: keir s. Cancer Chemother Pharmacol. 1998;41(6):485-90. doi: 10.1007/s002800050771. Cancer Chemother Pharmacol. 1998. PMID: 9554593

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

217 results

Search Page

Filters